CABIO Bioengineering (Wuhan) Co Ltd

CABIO Bioengineering (Wuhan) Co Ltd

Sales markets: Western Europe | Eastern Europe | Middle East | Asia | Australia | North America | Africa | Central/South America

About us

CABIO Bioengineering (Wuhan) Co Ltd (CABIO), is a hi-tech venture jointly founded by Wuhan Alking Bioengineering Co Ltd.and Cargill Incorporated. It has two wholly-owned subsidiaries in Gedian and Jiangxia respectively.

CABIO is the first company in China to engage in the production of unsaturated fatty acid with fermentation technology;which mainly serves ARA and Docosahexaenoic acid derived from microalga(DHA algal oil) and other high-end food ingredients; is the leading brand in the ARA industry in China; is the only Chinese company whose ARA products have been approved as the NOVEL FOOD by European Commission and as GRAS by the U.S. FDA. We have taken the leading role in drafting state standards for food safety regarding ARA and DHA (with the fermentation method); and have two advanced plants manufacturing ARA and DHA monomers currently.
Read more

Categories affiliated with CABIO Bioengineering (Wuhan) Co Ltd

CABIO Bioengineering (Wuhan) Co Ltd

Contact information




View all contact information